Skip to main content
SpringerLink
Log in

Behçet’s disease: immunological relevance with arthritis of ankylosing spondylitis

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Behçet’s disease (BD) is a multi-system inflammatory disorder, in which cytokine balance is polarized to Th1. In this study, the cell surface molecule expression, Th1/Th2, inflammatory cytokine levels in blood, and synovial fluid of CD3+ T lymphocytes in BD were investigated. The study group consisted of 10 BD, 10 ankylosing spondylitis (AS) patients with peripheral arthritis, and 10 healthy subjects. Expression of cell surface molecules, intracellular IL-2, IL-5, IL-8, IL-10, IL-12, IFN-γ, and TNF-α levels in CD3+ T lymphocytes were determined by flow cytometry in synovial and peripheral blood mononuclear cells (PBMCs). Synovial and plasma cytokine levels were measured by ELISA and CBA. In PBMCs, CD4, CD25, HLA-DR expression and intracellular IL-12, and TNF-α levels of CD3+ T lymphocytes were statistically increased in BD patients compared to healthy subjects. Compare to AS patients, CD25 and HLA-DR surface expression and intracellular IFN-γ and TNF-α levels in T cells were significantly elevated in BD patients. In BD patients, there was an increase in IL-8 secretion; however, in AS patients, both Th1- and Th2-type cytokines were increased compare to healthy subjects. Intracellular cytokine expression did not show any difference in BD patients; however, IL-12 content of synovial fluid was significantly increased compared to AS patients. Our findings revealed that Th1 polarization occurred in both peripheral blood and synovial fluid of BD patients with arthritis. It is found no difference between synovial fluid analysis of BD and AS patients, showing the similarities in the pathogenesis of both diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. The International Study Group for Behçet’s Disease (1992) Evaluation of diagnostic (‘classification’) criteria in Behçet’s disease—towards internationally agreed criteria. Br J Rheumatol 31:299–308

    Article  Google Scholar 

  2. Kaneko F, Togashi A, Saito S et al (2011) Behçet’s disease (Adamantiades-Behçet’s disease). Clin Dev Immunol 2011:681956

    Article  PubMed  Google Scholar 

  3. Esin S, Gül A, Hodara V, Jeddi-Tehrani M, Dilsen N, Koniçe M, Andersson R, Wigzell H (1997) Peripheral blood T cell expansions in patients with Behcet’s disease. Clin Exp Immunol 107:520–527

    Article  PubMed  CAS  Google Scholar 

  4. Kim J, Park JA, Lee EY, Lee YJ, Song YW, Lee EB (2010) Imbalance of Th17 to Th1 cells in Behçet’s disease. Clin Exp Rheumatol 28:S16–S19

    PubMed  Google Scholar 

  5. Ilhan F, Demir T, Türkçüoğlu P, Turgut B, Demir N, Gödekmerdan A (2008) Th1 polarization of the immune response in uveitis in Behçet’s disease. Can J Ophthalmol 43:105–108

    Article  PubMed  Google Scholar 

  6. Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today 14:426–430

    Article  PubMed  CAS  Google Scholar 

  7. Harrington LE, Hatton RD, Mangan PR et al (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123–1132

    Article  PubMed  CAS  Google Scholar 

  8. Moll C, Bogas M, Gómez-Puerta JA et al (2009) Macroscopic features of knee synovitis in early untreated Behçet disease and psoriatic arthritis. Clin Rheumatol 28:1053–1057

    Article  PubMed  Google Scholar 

  9. Cañete JD, Celis R, Noordenbos T et al (2009) Distinct synovial immunopathology in Behçet disease and psoriatic arthritis. Arthritis Res Ther 11:R17

    Article  PubMed  Google Scholar 

  10. Amberger M, Groll S, Günaydin I, Deuter C, Vonthein R, Kötter I (2007) Intracellular cytokine patterns in Behçet’s disease in comparison to ankylosing spondylitis–influence of treatment with interferon-alpha2a. Clin Exp Rheumatol 25:S52–S57

    PubMed  CAS  Google Scholar 

  11. Dalghous AM, Freysdottir J, Fortune F (2006) Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet’s disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD. Scand J Rheumatol 35:472–475

    Article  PubMed  CAS  Google Scholar 

  12. Charteris DG, Barton K, McCartney AC, Lightman SL (1992) CD4+ lymphocyte involvement in ocular Behçet’s disease. Autoimmunity 12:201–206

    Article  PubMed  CAS  Google Scholar 

  13. Mochizuki M, Morita E, Yamamoto S, Yamana S (1997) Characteristics of T cell lines established from skin lesions of Behçet’s disease. J Dermatol Sci 15:9–13

    Article  PubMed  CAS  Google Scholar 

  14. Gül A, Esin S, Dilsen N, Koniçe M, Wigzell H, Biberfeld P (1995) Immunohistology of skin pathergy reaction in Behçet’s disease. Br J Dermatol 132:901–907

    Article  PubMed  Google Scholar 

  15. Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M (1998) Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet’s disease. Invest Ophthalmol Vis Sci 39:996–1004

    PubMed  CAS  Google Scholar 

  16. Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163–189

    Article  PubMed  CAS  Google Scholar 

  17. Akdis M, Burgler S, Crameri R et al (2011) Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol 127(3):701-21.e1-70

    Google Scholar 

  18. Raziuddin S, al-Dalaan A, Bahabri S, Siraj AK, al-Sedairy S (1998) Divergent cytokine production profile in Behçet’s disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol 25:329–333

    PubMed  CAS  Google Scholar 

  19. Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroğlu IC, Dündar S, Kirazli S (1996) Cytokines in Behçet’s disease. J Rheumatol 23:321–322

    PubMed  CAS  Google Scholar 

  20. Evereklioglu C, Er H, Türköz Y, Cekmen M (2002) Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet’s disease. Mediators Inflamm 11:87–93

    Article  PubMed  CAS  Google Scholar 

  21. Alpsoy E, Cayirli C, Er H, Yilmaz E (1998) The levels of plasma interleukin-2 and soluble interleukin-2R in Behçet’s disease: a marker of disease activity. J Dermatol 25:513–516

    PubMed  CAS  Google Scholar 

  22. Ertenli I, Kiraz S, Calgüneri M et al (2001) Synovial fluid cytokine levels in Behçet’s disease. Clin Exp Rheumatol 19:S37–S41

    Article  PubMed  CAS  Google Scholar 

  23. Aridogan BC, Yildirim M, Baysal V, Inaloz HS, Baz K, Kaya S (2003) Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet’s disease. J Dermatol 30:602–607

    PubMed  CAS  Google Scholar 

  24. Nagalakshmi ML, Murphy E, McClanahan T, de Waal Malefyt R (2004) Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int Immunopharmacol 4:577–592

    Article  PubMed  CAS  Google Scholar 

  25. de Waal Malefyt R, Haanen J, Spits H et al (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915–924

    Article  PubMed  CAS  Google Scholar 

  26. Mizuki N, Meguro A, Ota M et al (2010) Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet’s disease susceptibility loci. Nat Genet 42:703–706

    Article  PubMed  CAS  Google Scholar 

  27. Remmers EF, Cosan F, Kirino Y et al (2010) Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet’s disease. Nat Genet 42:698–702

    Article  PubMed  CAS  Google Scholar 

  28. Mukaida N (2000) Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 72:391–398

    PubMed  CAS  Google Scholar 

  29. Durmazlar SP, Ulkar GB, Eskioglu F, Tatlican S, Mert A, Akgul A (2009) Significance of serum interleukin-8 levels in patients with Behcet’s disease: high levels may indicate vascular involvement. Int J Dermatol 48:259–264

    Article  PubMed  CAS  Google Scholar 

  30. Freire Ade L, Bertolo MB, de Pinho AJ, Samara AM Jr, Fernandes SR (2004) Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet’s disease. Clin Rheumatol 23:203–205

    Article  PubMed  Google Scholar 

  31. Zouboulis CC, Katsantonis J, Ketteler R et al (2000) Adamantiades-Behçet’s disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 292:279–284

    Article  PubMed  CAS  Google Scholar 

  32. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17:331–367

    Article  PubMed  CAS  Google Scholar 

  33. Ahn JK, Yu HG, Chung H, Park YG (2006) Intraocular cytokine environment in active Behçet uveitis. Am J Ophthalmol 142:429–434

    Article  PubMed  CAS  Google Scholar 

  34. Oztas MO, Onder M, Gurer MA, Bukan N, Sancak B (2005) Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet’s disease. Clin Exp Dermatol 30:61–63

    Article  PubMed  CAS  Google Scholar 

  35. Pay S, Erdem H, Pekel A et al (2006) Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet’s disease. Does interleukin-1beta play a major role in Behçet’s synovitis? Rheumatol Int 26:608–613

    Article  PubMed  CAS  Google Scholar 

  36. Turan B, Pfister K, Diener PA et al (2008) Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet’s disease. Scand J Rheumatol 37:135–141

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Research Fund of The University of Istanbul.

Author information

Authors and Affiliations

  1. Department of Immunology, Institute of Experimental Medicine (DETAE), Istanbul University, Vakif Gureba Caddesi, Sehremini, 34393, Istanbul, Turkey

    Esin Aktas Cetin, Fulya Cosan, Umut Can Kucuksezer, Sema Bilgic & Gunnur Deniz

  2. Division of Rheumatology, Department of Internal Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

    Yonca Cagatay & Ahmet Gul

Authors
  1. Esin Aktas Cetin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fulya Cosan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Umut Can Kucuksezer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sema Bilgic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yonca Cagatay
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ahmet Gul
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gunnur Deniz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Esin Aktas Cetin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aktas Cetin, E., Cosan, F., Kucuksezer, U.C. et al. Behçet’s disease: immunological relevance with arthritis of ankylosing spondylitis. Rheumatol Int 33, 733–741 (2013). https://doi.org/10.1007/s00296-012-2446-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-012-2446-9

Keywords

Search

Navigation